PORTLAND, Ore., March 06, 2018 -- Electro Scientific Industries Inc. (NASDAQ:ESIO), an innovator of laser-based manufacturing solutions for the microtechnology industry, will host its 2018 Investor and Analyst Conference in New York on March 21. At the conference, ESI’s executive management team will provide insight into the company’s growth strategy and market focus.
ESI’s 2018 Investor and Analyst Conference will be held at The Westin New York Hotel, located at 270 West 43rd Street. This event will feature presentations by ESI’s Chief Executive Officer, Michael Burger, and Chief Financial Officer, Allen Muhich, plus other members of the company’s executive staff. Q&A briefings with ESI’s executives will also be held following the formal presentations and luncheon.
Those who plan to attend the conference should register at go.esi.com/esi2018FAC for more information.
About ESI, Inc.
ESI enables our customers to commercialize technology using precision laser processes. ESI’s solutions produce the industry’s highest quality and throughput, and target the lowest total cost of ownership. ESI is headquartered in Portland, Oregon, with global operations and subsidiaries in Asia, Europe and North America. More information is available at www.esi.com.
Brian Smith
ESI
503-672-5760
[email protected]


Qantas Shares Climb as Long-Haul Pilot Deal Eases Strike Concerns
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised
Nvidia to Invest Up to $3 Billion in Blackstone-Backed Lancium
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook
DHL Q2 Profit Jumps 24% as Express Business Drives Growth
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 



